tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PTCT Stock Latest News

PTC Therapeutics price target lowered to $70 from $72 at Baird
The FlyPTC Therapeutics price target lowered to $70 from $72 at Baird
22h ago
PTCT
PTC Therapeutics price target raised to $56 from $52 at TD Cowen
PremiumThe Fly
PTC Therapeutics price target raised to $56 from $52 at TD Cowen
23h ago
PTCT
PTC Therapeutics price target raised to $63 from $60 at RBC Capital
PremiumThe Fly
PTC Therapeutics price target raised to $63 from $60 at RBC Capital
23h ago
PTCT
PTC Therapeutics price target raised to $79 from $78 at Wells Fargo
PremiumThe Fly
PTC Therapeutics price target raised to $79 from $78 at Wells Fargo
1d ago
PTCT
PTC Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
PTC Therapeutics Reports Q2 2025 Financial Results
1d ago
PTCT
PTC Therapeutics: Balancing Optimism and Uncertainty Amidst New Product Launches and Regulatory Decisions
PremiumRatingsPTC Therapeutics: Balancing Optimism and Uncertainty Amidst New Product Launches and Regulatory Decisions
1d ago
PTCT
PTC Therapeutics Enters Rights Satisfaction Agreement
Premium
Company Announcements
PTC Therapeutics Enters Rights Satisfaction Agreement
2d ago
8K
PTCT
PTC Therapeutics Announces Q2 2025 Financial Results
Premium
Company Announcements
PTC Therapeutics Announces Q2 2025 Financial Results
2d ago
8K
PTCT
PTC Therapeutics reports Q2 EPS (83c), consensus ($1.06)
PremiumThe Fly
PTC Therapeutics reports Q2 EPS (83c), consensus ($1.06)
2d ago
PTCT
PTC Therapeutics reports Q2 EPS (83c), consensus ($1.06)
PremiumThe Fly
PTC Therapeutics reports Q2 EPS (83c), consensus ($1.06)
2d ago
PTCT
PTC Therapeutics: Strategic Shift and Robust Financials Drive Buy Rating with $68 Target by 2025
PremiumRatings
PTC Therapeutics: Strategic Shift and Robust Financials Drive Buy Rating with $68 Target by 2025
2d ago
PTCT
PTC Therapeutics price target raised to $68 from $67 at JPMorgan
PremiumThe Fly
PTC Therapeutics price target raised to $68 from $67 at JPMorgan
2d ago
PTCT
PTC Therapeutics (PTCT) Q2 Earnings Cheat Sheet
PremiumPre-EarningsPTC Therapeutics (PTCT) Q2 Earnings Cheat Sheet
4d ago
PTCT
PTC Therapeutics’ Future at Risk: Navigating Operational and Financial Challenges
Premium
Company Announcements
PTC Therapeutics’ Future at Risk: Navigating Operational and Financial Challenges
9d ago
PTCT
PTC Therapeutics price target raised to $84 from $68 at BofA
Premium
The Fly
PTC Therapeutics price target raised to $84 from $68 at BofA
11d ago
PTCT
PTC Therapeutics Receives Buy Rating Following FDA Approval of Sephience and Strategic Market Positioning
PremiumRatings
PTC Therapeutics Receives Buy Rating Following FDA Approval of Sephience and Strategic Market Positioning
11d ago
PTCT
PTC Therapeutics price target raised to $86 from $80 at Truist
PremiumThe Fly
PTC Therapeutics price target raised to $86 from $80 at Truist
11d ago
PTCT
PTC Therapeutics: Buy Rating Driven by Sephience Approval and Market Strategy
PremiumRatings
PTC Therapeutics: Buy Rating Driven by Sephience Approval and Market Strategy
11d ago
PTCT
PTC Therapeutics price target raised to $78 from $74 at Wells Fargo
PremiumThe Fly
PTC Therapeutics price target raised to $78 from $74 at Wells Fargo
11d ago
PTCT
Positive Outlook for PTC Therapeutics: Buy Rating Affirmed Following Sephience Approval and Strategic Launch
PremiumRatingsPositive Outlook for PTC Therapeutics: Buy Rating Affirmed Following Sephience Approval and Strategic Launch
11d ago
PTCT
PTC Therapeutics price target raised to $80 from $71 at UBS
Premium
The Fly
PTC Therapeutics price target raised to $80 from $71 at UBS
11d ago
PTCT
Positive Outlook for PTC Therapeutics’ Sephience: Strong Market Potential and Revenue Prospects
Premium
Ratings
Positive Outlook for PTC Therapeutics’ Sephience: Strong Market Potential and Revenue Prospects
11d ago
PTCT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >